Recent Quotes (30 days)

You have no recent quotes
chg | %

Reckitt Benckiser Group Plc news

   Watch this stock
Showing stories 1 - 7 of about 7   

Articles published

RB 6,589.49 -38.51 (-0.58%)
price chart
Moolchand raises Rs 100 crore from Sequoia Capital
Sequoia Capital has invested in a number of healthcare companies in India, including in Vasan Healthcare Pvt. Ltd, Paras Pharmaceuticals Ltd (acquired by Reckitt Benckiser Group Plc), and Glocal Healthcare Systems Pvt. Ltd. The Moolchand funding is the ...
Euro debt crisis: should investors prepare for a Greek exit?
... the wider economy in the UK and Europe is important, but the growth is coming from the emerging world and Asia, particularly in the consumer staples sector where companies such as Diageo, Unilever and Reckitt Benckiser are focusing on these regions.
Billionaire Godrej Sees Property Beating Retail
Eldest daughter Tanya Dubash, 43, is on the boards of group companies Godrej Consumer and Godrej Industries. Daughter ... Godrej holds the lead in home insecticides, with 33.9 percent of the market, followed by Reckitt Benckiser Plc with 23.5 percent.
Addict cost company �2.4m after Nurofen contamination scare at Boots
A codeine addict who contaminated packets of Nurofen Plus to fund his habit is due to be sentenced. Christopher McGuire saved himself just �7 by placing strips of an anti-psychotic drug in empty packets of the painkiller and swapping them for new ...
Health scare caused by man swapping Nurofen for prescription drugs
Drug company Reckitt Benckiser suffered losses of �2.4m in the wake of the scare after 31-year-old Christopher McGuire replaced Nurofen tablets with Seroquel, a prescription drug used to treat schizophrenia.
Moody's: Oil & Gas companies to benefit from higher oil prices resulting from ...
London, 22 May 2012 -- Higher oil prices that could potentially result from new US and European Union (EU) economic sanctions against Iranian oil exports would be credit-positive for international oil companies (IOCs) overall, but negative for ...
Pliazon� cream now available for metastatic colorectal cancer patients
London, 28th May 2012 - Today, Merck Serono announced that they will provide Pliazon�, a cream for the treatment of skin reactions, free to all UK patients undergoing anti-EGFR antibody therapy for metastatic colorectal cancer (mCRC).